Health Update

Not much to report this month. My M-protein level—a proxy for the level of cancerous plasma cells in my bone marrow—is down from 0.48 in February to 0.43 in March. That’s not a big drop, but it’s a drop, and anything moving in the right direction is good news. Apparently the evil dex is reluctantly doing its job.

FWIW, there are other markers besides M-protein that I haven’t been sharing because they’re all basically OK and haven’t changed much. For example, we routinely measure something call Kappa light chains, and it’s been at a nice low level ever since the first round of chemotherapy. Ditto for my IgG immunoglobulin levels. (There are three types of immunoglobulins corresponding to three different types of multiple myeloma. I have the G version.) This is all good news. If we can just get the basic level of cancerous cells down close to zero, I’ll be in pretty good shape. In fact, it’s even possible that the slow response of the M-protein level is a positive thing, since it would be expected if I have a very slow-moving version of multiple myeloma. That’s just speculation at this point since there’s no way of knowing, but it fits the evidence so far.


We recently wrapped up the crowdfunding campaign for our ambitious Mother Jones Corruption Project, and it was a smashing success. About 10,364 readers pitched in with donations averaging $45, and together they contributed about $467,374 toward our $500,000 goal.

That's amazing. We still have donations from letters we sent in the mail coming back to us, so we're on pace to hit—if not exceed—that goal. Thank you so much. We'll keep you posted here as the project ramps up, and you can join the hundreds of readers who have alerted us to corruption to dig into.

We Recommend


Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.


Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.


Share your feedback: We’re planning to launch a new version of the comments section. Help us test it.